Literature DB >> 15970297

Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats.

Chen Xiong1, Yongshan Mou, Jifeng Zhang, Mingui Fu, Yuqing E Chen, Mukaila A Akinbami, Taixing Cui.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPAR gamma), a member of the nuclear receptor family, has been implicated in the regulation of vascular smooth muscle cell (VSMC) growth; however, the underlying mechanisms are still not fully understood. We hypothesized that PPAR gamma functional deficiency may contribute to the enhanced proliferation of VSMC associated with hypertension in spontaneously hypertensive rats (SHR). We observed that PPAR gamma mRNA level in SHR VSMC was 3 approximately 4 fold higher than that from Wistar-Kyoto rats (WKY), but the protein expression levels of PPAR gamma are significantly lower in SHR than WKY VSMC, suggesting an impaired control of PPAR gamma protein expression in SHR VSMC. The deficiency of PPAR gamma protein expression in SHR VSMC was demonstrated by PPAR gamma reporter gene assays. Furthermore, the exaggerated growth of SHR VSMC was markedly attenuated by adenoviral PPAR gamma overexpression. Taken together, our results provided the first direct evidence that impaired expression of PPAR gamma protein contributes to the exaggerated growth of SHR VSMC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970297     DOI: 10.1016/j.lfs.2005.02.032

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.

Authors:  Lili Zhang; Peng Xie; Jingzhou Wang; Qingwu Yang; Chuanqin Fang; Shuang Zhou; Jingcheng Li
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

2.  Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.

Authors:  Kaizheng Gong; Dongqi Xing; Peng Li; Baran Aksut; Namasivayam Ambalavanan; Qinglin Yang; Susan E Nozell; Suzanne Oparil; Yiu-Fai Chen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-16       Impact factor: 5.464

Review 3.  PPARs and the cardiovascular system.

Authors:  Milton Hamblin; Lin Chang; Yanbo Fan; Jifeng Zhang; Y Eugene Chen
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

4.  Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study).

Authors:  Manjunath Krishnappa; Kishor Patil; Krupi Parmar; Purav Trivedi; Nirali Mody; Chintan Shah; Khushboo Faldu; Sanjay Maroo; Deven Parmar
Journal:  Cardiovasc Diabetol       Date:  2020-06-19       Impact factor: 9.951

5.  The role of peroxisome proliferator-activated receptor gamma in blood pressure regulation.

Authors:  Milton Hamblin; Lin Chang; Jifeng Zhang; Y Eugene Chen
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 4.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.